Contrarian Corpus
short seller full deck initial thesis
2021-02-16 · 77 pages

Leidos Holdings, Inc. LDOS

Leidos is concealing defective explosive-detection products from its impaired $1bn L3Harris SD&A deal while inflating cash flow 67-78%; sell with 35-60% downside to $43-$70.

N 4 Narrative
V 3 Visual
C 3 Craft
Unlock to download PDF Spruce Point research ↗

Thesis

Leidos Holdings, the largest pure-play U.S. government IT services provider, paid $1.0bn in February 2020 for L3Harris's Security Detection & Automation (SD&A) business immediately before the pandemic collapsed global air travel. Spruce Point presents evidence the deal is already impaired: SD&A is tracking 59% below the $500m sales plan, ClearScan and MV3D units are being returned as defective, and L3Harris is losing share to Rohde & Schwarz and Smiths Detection. Management, led by CEO Roger Krone (a five-year direct subordinate of ousted Boeing CEO Dennis Muilenburg, whose 'culture of concealment' prioritized profits over safety), is allegedly inflating YTD'20 operating cash flow by 67-78%, backdating IMX Medical revenues, and channel-stuffing through a Thai distributor with foreign corruption ties. The firm demands a board investigation, termination of Krone and CFO Reagan, and values LDOS at $43-$70/share, 35-60% below the $107.85 reference price.

SCQA

Situation

Leidos Holdings is the largest pure-play U.S. government IT services provider and an S&P 500 member that, via the February 2020 $1.0bn L3Harris SD&A acquisition, now supplies mission-critical explosive and threat detection equipment to airports, ports, and borders globally.

Complication

The SD&A deal is running 59% below the $500m sales plan with defective ClearScan and MV3D units returned by international customers; management is concealing the impairment while inflating operating cash flow 67-78% and backdating organic growth.

Resolution

Sell LDOS shares; the board must launch an independent investigation of the SD&A transaction, write down the impaired asset, and terminate CEO Roger Krone and CFO James Reagan for due-diligence failures and misrepresenting results.

Reward

Valuing Leidos on normalized 2021E operating cash flow at a discount to peers yields a $43-$70 price target, 35-60% downside from $107.85, plus unquantifiable tail-risk to zero if defective detection equipment causes a security incident.

The three reasons

  1. 1

    L3Harris SD&A acquisition already impaired; defective ClearScan/MV3D units being returned, tracking 59% below plan

  2. 2

    Operating cash flow inflated an estimated 67-78% YTD'20; organic growth manipulated via IMX backdating and Thai channel stuffing

  3. 3

    CEO Krone, ex-Boeing subordinate of Muilenburg's 'culture of concealment', overseeing cover-up with 35-60% downside to $43-$70

Primary demands

  • Board should immediately investigate the $1.0bn L3Harris SD&A acquisition and disclose product defects and impairment
  • Terminate CEO Roger Krone and CFO James Reagan for due-diligence failures and misrepresenting the SD&A outlook
  • Write down L3Harris SD&A goodwill and intangibles as impaired; restate inflated operating cash flow and organic growth figures

KPIs cited

Price target / downside
$43-$70 per share, 35-60% downside from $107.85; low case -56%, high case -34%
Operating cash flow inflation
Estimated 67-78% overstatement of YTD'20 OCF versus underlying economics
SD&A acquisition sales vs. plan
Q3'20 $74m quarterly run-rate implies ~$297m annualized vs. $500m deal plan (59% shortfall)
Acquisition multiple paid
$1.0bn price = ~13.3x CY20 EBITDA / ~9.4x CY21; ~3.4x trailing sales vs. 2.5x precedent average
Street consensus vs. Spruce Point
Sell-side consensus $116.67 (+8.2% upside); 12 buy/outperform ratings from Credit Suisse to Goldman
Relative valuation on OCF
Leidos trades 24x 2021E OCF (Spruce Point adjusted 23.5x) vs. 16x peer median (12.0x avg)
UAE subsidiary restatement risk
MacDonald Humfrey UAE 2018 sales and net income overstated by 68% and 98% per foreign filing
Cash quality adjustment
$512m reported cash includes $166m 'outstanding payments' plus $215m 1901 Group acquisition outflow
Market share in baggage detection
Smiths ~60% vs. L3Harris/Leidos ~40%; losing share in whole-body millimeter-wave to Rohde & Schwarz at 8-10% price discount

Pattern membership

Where this document fits across the library's 12 rhetorical / structural patterns. Orange cells are present in this deck; neutral cells are not.

Precedents cited

  • Maxar Technologies (MAXR) short (Aug 2018)
  • Mercury Systems (MRCY) short (Apr 2018)
  • Forescout Technologies (FSCT) short (May 2020)
  • Church & Dwight (CHD) short (Sep 2019)
  • AMETEK (AME) short (Nov 2014)
  • Mettler Toledo (MTD) short (Jul 2019)
  • AO Smith (AOS) short (May 2019)
  • Boeing 737 MAX 'culture of concealment' (Muilenburg)
  • L3 Communications 2014 accounting scandal; Revolution Lighting (RVLT) SEC fraud charges

Composition what's on the 77 slides

Visual + textual elements counted across every slide in this deck. Hover a box for what that element is; click to see every slide in the corpus that uses it.

Slide gallery ·

All 77
No slide inventory yet

Pass-2 extraction may still be in progress for this deck.

Notes

Classic Spruce Point short report: photoreal cover (airport x-ray with rats and toxic box), teal/grey branded deck, 'Promotion vs. Reality' two-column framing throughout. Strong forensic playbook signals: CEO-quote-contradiction matrix on slide 15; track-record-of-prior-shorts table on slides 5-6 (Maxar/Mercury/Forescout/CHD/AME/MTD/AOS) used as credibility precedent; expert-interview paraphrase slide. Thesis stacks fraud_exposure (defective products, channel stuffing, foreign subsidiary restatement), governance (CAO criminal record, ex-Boeing CEO with 'culture of concealment' lineage), and accounting (OCF inflation, deferred revenue, cash overstated). Valuation is a straight peer-OCF multiple — no sum-of-parts. Stake field null: short-seller, no long equity stake. Ben Axler named only via quoted pullout on slide 6; firm-authored otherwise.